XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Tables)
9 Months Ended
Oct. 01, 2021
Stockholders Equity Note [Abstract]  
Schedule of Compensation Cost

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

October 1, 2021

 

 

October 2, 2020

 

 

October 1, 2021

 

 

October 2, 2020

 

Employee stock options

 

$

2,594

 

 

$

2,469

 

 

$

7,850

 

 

$

7,206

 

Restricted stock

 

 

109

 

 

 

119

 

 

 

507

 

 

 

273

 

Restricted stock units

 

 

700

 

 

 

415

 

 

 

2,048

 

 

 

1,238

 

Performance stock units

 

 

124

 

 

 

54

 

 

 

325

 

 

 

54

 

Nonemployee stock options

 

 

136

 

 

 

69

 

 

 

255

 

 

 

194

 

Total stock-based compensation expense

 

$

3,663

 

 

$

3,126

 

 

$

10,985

 

 

$

8,965

 

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation costs in the following categories (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

October 1, 2021

 

 

October 2, 2020

 

 

October 1, 2021

 

 

October 2, 2020

 

Cost of sales

 

$

61

 

 

$

30

 

 

$

150

 

 

$

82

 

General and administrative

 

 

1,671

 

 

 

1,307

 

 

 

4,925

 

 

 

3,601

 

Selling and marketing

 

 

851

 

 

 

807

 

 

 

2,637

 

 

 

2,674

 

Research and development

 

 

1,080

 

 

 

982

 

 

 

3,273

 

 

 

2,608

 

Total stock-based compensation expense, net

 

 

3,663

 

 

 

3,126

 

 

 

10,985

 

 

 

8,965

 

Amounts capitalized as part of inventory

 

 

383

 

 

 

287

 

 

 

1,082

 

 

 

847

 

Total stock-based compensation expense, gross

 

$

4,046

 

 

$

3,413

 

 

$

12,067

 

 

$

9,812

 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

October 1, 2021

 

 

October 2, 2020

 

 

October 1, 2021

 

 

October 2, 2020

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

53

%

 

 

53

%

 

 

53

%

 

 

53

%

Risk-free interest rate

 

 

0.79

%

 

 

0.31

%

 

 

0.84

%

 

 

0.53

%

Expected term (in years)

 

 

5.38

 

 

 

5.72

 

 

 

5.38

 

 

 

5.72

 

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity under the Plan for nine months ended October 1, 2021 is presented below:

 

 

 

Stock

Options

(in 000’s)

 

 

Minimum

Exercise

Price

 

 

Maximum

Exercise

Price

 

Outstanding at January 1, 2021

 

 

3,418

 

 

 

 

 

 

 

 

 

Granted

 

 

268

 

 

 

 

 

 

 

 

 

Exercised

 

 

(1,089

)

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(27

)

 

 

 

 

 

 

 

 

Outstanding at October 1, 2021

 

 

2,570

 

 

$

5.34

 

 

$

154.96

 

Exercisable at October 1, 2021

 

 

1,864

 

 

 

 

 

 

 

 

 

 

Schedule of Share-based Compensation, Restricted Stock, RSUs and PSUs Activity

A summary of restricted stock, RSUs and PSUs activity under the Plan for the nine months ended October 1, 2021 is presented below (shares in thousands):

 

 

 

Restricted

Stock

 

 

RSUs

 

 

PSUs

 

Unvested at January 1, 2021

 

 

11

 

 

 

122

 

 

 

15

 

Granted

 

 

3

 

 

 

63

 

 

 

 

Vested

 

 

(11

)

 

 

(54

)

 

 

(5

)

Forfeited or expired

 

 

 

 

 

 

 

 

 

Unvested at October 1, 2021

 

 

3

 

 

 

131

 

 

 

10